Catalyst Wire Dossier Catalyst Wire Dossier

Lyvdelzi

seladelpar lysine dihydrate · Gilead Sciences Ireland Unlimited Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lyvdelzi, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: EMA Authorised: Lyvdelzi (previously Seladelpar Gilead) (seladelpar lysine dihydrate) — Gilead Sciences Ireland Unlimited Company

See pricing